Beta Bionics, Inc. (BBNX): Cash & Equivalents
$31.58M
As of 2025-12-31
$44.32M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $31.58M | +3.8% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $30.43M | +14.6% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $26.57M | n/a | 2025-03-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $31.58M | +3.8% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $21.69M | +61.5% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $99.71M | -58.0% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $69.75M | -1.6% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $57.48M | +3.3% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $199.28M | -25.6% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $43.45M | +34.1% |
| Iradimed Corp (IRMD) | 2025-12-31 | $51.16M | -2.1% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $50.84M | -3.5% |
Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗